Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRent ExpenseRestructuring CostsRevenueShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Acadia Healthcare Company (ACHC) EPS (Weighted Average and Diluted) (2016 - 2026)

Acadia Healthcare Company (ACHC) has disclosed EPS (Weighted Average and Diluted) for 17 consecutive years, with $0.05 as the latest value for Q1 2026.

  • For Q1 2026, EPS (Weighted Average and Diluted) fell 44.44% year-over-year to $0.05; the TTM value through Mar 2026 reached -$12.2, down 698.04%, while the annual FY2025 figure was -$12.16, 537.41% down from the prior year.
  • EPS (Weighted Average and Diluted) hit $0.05 in Q1 2026 for Acadia Healthcare Company, up from -$12.98 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.88 in Q2 2022 and bottomed at -$12.98 in Q4 2025.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.39, with a median of $0.67 recorded in 2022.
  • Year-over-year, EPS (Weighted Average and Diluted) skyrocketed 509.09% in 2022 and then tumbled 3705.56% in 2025.
  • Acadia Healthcare Company's EPS (Weighted Average and Diluted) stood at $0.67 in 2022, then dropped by 5.97% to $0.63 in 2023, then tumbled by 42.86% to $0.36 in 2024, then plummeted by 3705.56% to -$12.98 in 2025, then surged by 100.39% to $0.05 in 2026.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods came in at $0.05, -$12.98, and $0.4 for Q1 2026, Q4 2025, and Q3 2025 respectively.